Home Pilots Home allergy testing company Nectar secures $16.5M in funding Pilots Home allergy testing company Nectar secures $16.5M in funding By - December 20, 2022 25 0 Facebook Twitter Pinterest WhatsApp The investment will support the company’s growth nationwide, fund clinical trials and open a physical location. RELATED ARTICLESMORE FROM AUTHOR Pilots Medtronic issues voluntary recall of MiniMed insulin pumps Pilots Hybrid primary care company Rezilient Health scores $10M Pilots Empathy Health Technologies raises $2.8M for Sober Sidekick app LEAVE A REPLY Cancel reply Please enter your comment! Please enter your name here You have entered an incorrect email address! Please enter your email address here Save my name, email, and website in this browser for the next time I comment. FOLLOW ME0FansLike0FollowersFollow0SubscribersSubscribe POPULAR ARTICLES AI-based patch in Singapore can track wound healing status without battery Pilots - June 30, 2023 0 Paradigm launches with $203M funding round to expand clinical trial access Pilots - January 27, 2023 0 Study flags safety risks with Australian prescription apps Pilots - March 20, 2023 0 Wellth raises $20M for health app with financial rewards Pilots - April 3, 2023 0 FOLX Health expands mental health support with Crisis Text Line partnership Pilots - March 27, 2024 0 POPULAR CATEGORIESPilots2166Applications682Testing237Collaborations15GitHub3